Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1264K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Andersson, J. Articles by Shevach, E. M. Search for Related Content PubMed PubMed Citation Articles by Andersson, J. Articles by Shevach, E. M. Related Collections Related In this Issue article Social Bookmarking                            What's this?

¹ Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), and ² Molecular Immunology and Inflammation Branch, National Institute for Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD 20892

CORRESPONDENCE Ethan M. Shevach: eshevach{at}niaid.nih.gov

CD4⁺FoxP3⁺ regulatory T (T reg) cells comprise a separate lineage of T cells that are essential for maintaining immunological tolerance to self. The molecular mechanism(s) by which T reg cells mediate their suppressive effects remains poorly understood. One molecule that has been extensively studied in T reg cell suppression is transforming growth factor (TGF)-β, but its importance remains controversial. We found that TGF-β complexed to latency-associated peptide (LAP) is expressed on the cell surface of activated but not resting T reg cells. T reg cell LAP–TGF-β plays an important role in the suppression of the proliferation of activated T cells, but it is not required for the suppression of naive T cell activation. More importantly, T reg cell–derived TGF-β could generate de novo CD4⁺FoxP3⁺ T cells in vitro from naive precursors in a cell contact–dependent, antigen-presenting cell–independent and _V integrin–independent manner. The newly induced CD4⁺FoxP3⁺ T cells are suppressive both in vitro and in vivo. Transfer of activated antigen-specific T reg cells with naive antigen-specific responder T cells to normal recipients, followed by immunization, also results in induction of FoxP3 expression in the responder cells. T reg cell–mediated generation of functional CD4⁺FoxP3⁺ cells via this TGF-β–dependent pathway may represent a major mechanism as to how T reg cells maintain tolerance and expand their suppressive abilities.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Miao, C. H., Harmeling, B. R., Ziegler, S. F., Yen, B. C., Torgerson, T., Chen, L., Yau, R. J., Peng, B., Thompson, A. R., Ochs, H. D., Rawlings, D. J. (2009). CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood 114: 4034-4044 [Abstract] [Full Text]  
• Bollyky, P. L., Falk, B. A., Long, S. A., Preisinger, A., Braun, K. R., Wu, R. P., Evanko, S. P., Buckner, J. H., Wight, T. N., Nepom, G. T. (2009). CD44 Costimulation Promotes FoxP3+ Regulatory T Cell Persistence and Function via Production of IL-2, IL-10, and TGF-{beta}. J. Immunol. 183: 2232-2241 [Abstract] [Full Text]  
• Tran, D. Q., Andersson, J., Wang, R., Ramsey, H., Unutmaz, D., Shevach, E. M. (2009). GARP (LRRC32) is essential for the surface expression of latent TGF-{beta} on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13445-13450 [Abstract] [Full Text]  
• Wang, R., Kozhaya, L., Mercer, F., Khaitan, A., Fujii, H., Unutmaz, D. (2009). Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13439-13444 [Abstract] [Full Text]  
• Pillemer, B. B. L., Qi, Z., Melgert, B., Oriss, T. B., Ray, P., Ray, A. (2009). STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells. J. Immunol. 183: 155-163 [Abstract] [Full Text]  
• Tran, D. Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G. G., Shevach, E. M. (2009). Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 113: 5125-5133 [Abstract] [Full Text]  
• Ahn, Y.-O., Lee, J.-C., Sung, M.-W., Heo, D. S. (2009). Presence of Membrane-Bound TGF-{beta}1 and Its Regulation by IL-2-Activated Immune Cell-Derived IFN-{gamma} in Head and Neck Squamous Cell Carcinoma Cell Lines. J. Immunol. 182: 6114-6120 [Abstract] [Full Text]  
• Game, D. S., Cao, X., Jiang, S. (2008). Regulatory T Cells: The Cunning Fox and Its Clinical Application. Sci Signal 1: mr3-mr3 [Abstract] [Full Text]  
• Sun, J.-B., Flach, C.-F., Czerkinsky, C., Holmgren, J. (2008). B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit. J. Immunol. 181: 8278-8287 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS